Skip Navigation

Research

Global Projects

Map

Ultra Curto TB

Rio de Janerio, Brazil


Summary

This Phase 4 clinical trial is comparing adherence to and safety of two ultra-short TB preventive therapy regimens in household contacts in Brazil. The study will randomize 500 individuals to a one-month course of daily rifapentine and isoniazid (1HP) or three months of weekly rifapentine and isoniazid (3HP). The study is in collaboration with the Rio de Janeiro Health Secretariat, Fiocruz, and the Foundation for Tropical Medicine in Manaus.

Dates

  • Start Date: 
    08/01/2020
  • End Date: 
    07/31/2025

Project Type

Locations

Researchers